Zoom in: In April, Sandoz's biosimilar known as Hyrimoz contributed to roughly 93% of all new prescriptions of Humira biosimilars. CVS' Cordavis unit began to co-brand Hyrimoz with Sandoz earlier ...

Despite the approval, US patients must wait until the US patent on Humira expires on September 30, 2023, at which time Hyrimoz can be legally prescribed. Meanwhile, the EU patent for AbbVie’s ...

The company’s Cordavis unit is now selling its own Humira biosimilar, Hyrimoz, as part of a collaboration with manufacturer Sandoz. In other words, CVS is one of the main sellers in a ...

Biosimilars for Humira include Amjevita, Abrilada, Cyltezo, Hyrimoz, Hadlima, Hulio, Yusimry, and others. Your doctor, pharmacist, or insurance provider can tell you more about the cost of these ...

EMA advisors at the Committee for Medicinal Products for Human Use (CHMP) recommended Sandoz’s adalimumab Humira biosimilar under three brand names – Halimatoz, Hefiya and Hyrimoz. The firm ...